The ligand PD-L1 (less PD-L2) is expressed on DCs, Mo/Ma, and numerous cancer cells, including melanoma, ovarian, breast, cervical, hematologic cancers, and non-small cell lung cancer. This evidence concerns the gene CD274 and hematopoietic and lymphoid cell neoplasm.